KORU Medical Systems, Inc.KRMDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +23.00% | +17.53% | +20.93% | +27.17% | +23.27% |
| Gross Profit Growth | +28.44% | +18.48% | +18.18% | +20.80% | +7.98% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.52% | +0.59% | +0.83% | +0.85% | +0.61% |
| Weighted Average Shares Diluted Growth | +0.52% | +0.59% | +0.83% | +0.85% | +0.61% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -14.33% | +0.00% | -4161.23% | +0.00% | +16.51% |
| Free Cash Flow Growth | +9.15% | +0.00% | +0.00% | +0.00% | -30.13% |
| Receivables Growth | +48.27% | +33.95% | -12.93% | +5.27% | +8.87% |
| Inventory Growth | -19.46% | +4.17% | +52.50% | +12.31% | +31.19% |
| Asset Growth | -4.37% | -1.03% | -6.55% | -1.05% | +3.61% |
| Book Value per Share Growth | -17.82% | -15.00% | -12.38% | -7.93% | +0.78% |
| Debt Growth | -10.24% | -10.58% | -12.60% | -13.46% | -12.37% |
| R&D Expense Growth | -13.46% | -24.47% | +5.34% | -39.17% | +2.74% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +16.91% | +0.00% |